epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Deconamine SR
    chlorpheniramine/ pseudoephedrine
  • remove Esgic
    butalbital/ acetaminophen/ caffeine
  • remove Viltepso
    viltolarsen

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Deconamine SR (chlorpheniramine/ pseudoephedrine) + Esgic (butalbital/ acetaminophen/ caffeine)

Avoid/Use Alternative


chlorpheniramine + butalbital

avoid combo: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

Monitor/Modify Tx


pseudoephedrine + caffeine

monitor BP, HR; avoid excessive caffeine intake: combo may incr. risk of HTN, tachycardia (additive effects)

Additional Considerations

Smiley face Smiley face pseudoephedrine in Deconamine SR

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information